These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Key Role of ROS in the Process of 15-Lipoxygenase/15-Hydroxyeicosatetraenoiccid-Induced Pulmonary Vascular Remodeling in Hypoxia Pulmonary Hypertension. Li Q; Mao M; Qiu Y; Liu G; Sheng T; Yu X; Wang S; Zhu D PLoS One; 2016; 11(2):e0149164. PubMed ID: 26871724 [TBL] [Abstract][Full Text] [Related]
5. Adventitial Fibroblast Nox4 Expression and ROS Signaling in Pulmonary Arterial Hypertension. Barman SA; Fulton D Adv Exp Med Biol; 2017; 967():1-11. PubMed ID: 29047077 [TBL] [Abstract][Full Text] [Related]
6. Macrophage migration inhibitory factor contributes to hypoxic pulmonary vasoconstriction in rats. Zhang B; Luo Y; Liu ML; Wang J; Xu DQ; Dong MQ; Liu Y; Xu M; Dong HY; Zhao PT; Gao YQ; Li ZC Microvasc Res; 2012 Mar; 83(2):205-12. PubMed ID: 22005047 [TBL] [Abstract][Full Text] [Related]
7. NOX4 regulates ROS levels under normoxic and hypoxic conditions, triggers proliferation, and inhibits apoptosis in pulmonary artery adventitial fibroblasts. Li S; Tabar SS; Malec V; Eul BG; Klepetko W; Weissmann N; Grimminger F; Seeger W; Rose F; Hänze J Antioxid Redox Signal; 2008 Oct; 10(10):1687-98. PubMed ID: 18593227 [TBL] [Abstract][Full Text] [Related]
8. Magnesium lithospermate B prevents phenotypic transformation of pulmonary arteries in rats with hypoxic pulmonary hypertension through suppression of NADPH oxidase. Li T; Luo XJ; Wang EL; Li NS; Zhang XJ; Song FL; Yang JF; Liu B; Peng J Eur J Pharmacol; 2019 Mar; 847():32-41. PubMed ID: 30659826 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of pirfenidone in the sugen/hypoxia rat model of severe pulmonary hypertension. Poble PB; Phan C; Quatremare T; Bordenave J; Thuillet R; Cumont A; Huertas A; Tu L; Dorfmüller P; Humbert M; Ghigna MR; Savale L; Guignabert C FASEB J; 2019 Mar; 33(3):3670-3679. PubMed ID: 30481487 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension. Takahashi H; Goto N; Kojima Y; Tsuda Y; Morio Y; Muramatsu M; Fukuchi Y Am J Physiol Lung Cell Mol Physiol; 2006 Mar; 290(3):L450-8. PubMed ID: 16361357 [TBL] [Abstract][Full Text] [Related]
11. Fluvastatin inhibits hypoxic proliferation and p38 MAPK activity in pulmonary artery fibroblasts. Carlin CM; Peacock AJ; Welsh DJ Am J Respir Cell Mol Biol; 2007 Oct; 37(4):447-56. PubMed ID: 17556673 [TBL] [Abstract][Full Text] [Related]
12. Grape seed procyanidin extract attenuates hypoxic pulmonary hypertension by inhibiting oxidative stress and pulmonary arterial smooth muscle cells proliferation. Jin H; Liu M; Zhang X; Pan J; Han J; Wang Y; Lei H; Ding Y; Yuan Y J Nutr Biochem; 2016 Oct; 36():81-88. PubMed ID: 27596528 [TBL] [Abstract][Full Text] [Related]
13. Atorvastatin attenuates homocysteine-induced migration of smooth muscle cells through mevalonate pathway involving reactive oxygen species and p38 MAPK. Bao XM; Zheng H Clin Exp Pharmacol Physiol; 2015 Aug; 42(8):865-73. PubMed ID: 26041506 [TBL] [Abstract][Full Text] [Related]
14. p38 MAP kinase: essential role in hypoxia-mediated human pulmonary artery fibroblast proliferation. Mortimer HJ; Peacock AJ; Kirk A; Welsh DJ Pulm Pharmacol Ther; 2007; 20(6):718-25. PubMed ID: 17055760 [TBL] [Abstract][Full Text] [Related]
15. Danshensu prevents hypoxic pulmonary hypertension in rats by inhibiting the proliferation of pulmonary artery smooth muscle cells via TGF-β-smad3-associated pathway. Zhang N; Dong M; Luo Y; Zhao F; Li Y Eur J Pharmacol; 2018 Feb; 820():1-7. PubMed ID: 29221952 [TBL] [Abstract][Full Text] [Related]
16. Antioxidant mechanism of Rutin on hypoxia-induced pulmonary arterial cell proliferation. Li Q; Qiu Y; Mao M; Lv J; Zhang L; Li S; Li X; Zheng X Molecules; 2014 Nov; 19(11):19036-49. PubMed ID: 25412048 [TBL] [Abstract][Full Text] [Related]
17. Role of HIF-1alpha in the regulation ACE and ACE2 expression in hypoxic human pulmonary artery smooth muscle cells. Zhang R; Wu Y; Zhao M; Liu C; Zhou L; Shen S; Liao S; Yang K; Li Q; Wan H Am J Physiol Lung Cell Mol Physiol; 2009 Oct; 297(4):L631-40. PubMed ID: 19592460 [TBL] [Abstract][Full Text] [Related]
18. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis. Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114 [TBL] [Abstract][Full Text] [Related]
19. Docosahexaenoic acid inhibits development of hypoxic pulmonary hypertension: in vitro and in vivo studies. Yan J; Chen R; Liu P; Gu Y Int J Cardiol; 2013 Oct; 168(4):4111-6. PubMed ID: 23907044 [TBL] [Abstract][Full Text] [Related]
20. The effect of activated κ-opioid receptor (κ-OR) on the role of calcium sensing receptor (CaSR) in preventing hypoxic pulmonary hypertension development. Li J; Jia M; Liu M; Cao Z; Wang X; Feng N; Gu X; Zhang S; Fan R; Guo H; Wang Y; Liu M; Pei J Biomed Pharmacother; 2020 May; 125():109931. PubMed ID: 32066040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]